Merck & Co. has settled a lawsuit over claims the drugmaker delayed releasing disappointing results of a study that management had hoped would instead boost sales of a key drug.
Merck, shareholders settle suit over heart drug study
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.